772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?
2015 ◽
Vol 21
(14)
◽
pp. 3170-3177
◽
2016 ◽
Vol 19
(8)
◽
pp. 777-784
◽
2020 ◽
Vol 3
(1)
◽
pp. 119-127
◽
2012 ◽
Vol 13
(10)
◽
pp. 983-992
◽
2011 ◽
Vol 47
◽
pp. S483-S484
◽